Debra Freedenberg

3.9k total citations
20 papers, 1.1k citations indexed

About

Debra Freedenberg is a scholar working on Genetics, Molecular Biology and Clinical Biochemistry. According to data from OpenAlex, Debra Freedenberg has authored 20 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Genetics, 6 papers in Molecular Biology and 6 papers in Clinical Biochemistry. Recurrent topics in Debra Freedenberg's work include Metabolism and Genetic Disorders (6 papers), Genetics and Neurodevelopmental Disorders (4 papers) and Cystic Fibrosis Research Advances (3 papers). Debra Freedenberg is often cited by papers focused on Metabolism and Genetic Disorders (6 papers), Genetics and Neurodevelopmental Disorders (4 papers) and Cystic Fibrosis Research Advances (3 papers). Debra Freedenberg collaborates with scholars based in United States, United Kingdom and France. Debra Freedenberg's co-authors include Michael Shevell, John B. Moeschler, Emily Chen, Joan M. Stoler, Rizwan Hamid, Marilyn C. Jones, Robert A. Saul, Beth A. Tarini, Stefan Koelker and Hye‐Seung Lee and has published in prestigious journals such as PLoS ONE, PEDIATRICS and Human Molecular Genetics.

In The Last Decade

Debra Freedenberg

20 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Debra Freedenberg United States 13 452 355 302 195 193 20 1.1k
Asuri N. Prasad Canada 25 339 0.8× 528 1.5× 427 1.4× 383 2.0× 77 0.4× 80 1.6k
Jesús Manuel Eirís Puñal Spain 16 169 0.4× 229 0.6× 152 0.5× 300 1.5× 99 0.5× 91 867
Mitsugu Uematsu Japan 20 175 0.4× 410 1.2× 94 0.3× 198 1.0× 50 0.3× 95 1.0k
Ana Chiesa Argentina 20 234 0.5× 467 1.3× 218 0.7× 222 1.1× 106 0.5× 70 1.1k
Harry J. Hirsch Israel 22 531 1.2× 412 1.2× 36 0.1× 248 1.3× 307 1.6× 70 1.3k
Huriya Beyan United Kingdom 17 721 1.6× 911 2.6× 103 0.3× 186 1.0× 265 1.4× 25 1.7k
Warren D. Grover United States 21 139 0.3× 592 1.7× 442 1.5× 173 0.9× 67 0.3× 61 1.3k
Anna Bergqvist United States 20 94 0.2× 182 0.5× 449 1.5× 146 0.7× 50 0.3× 50 1.3k
Patrick Rump Netherlands 21 487 1.1× 547 1.5× 39 0.1× 314 1.6× 69 0.4× 39 1.2k
Federica Zibordi Italy 21 131 0.3× 283 0.8× 164 0.5× 29 0.1× 44 0.2× 51 1.1k

Countries citing papers authored by Debra Freedenberg

Since Specialization
Citations

This map shows the geographic impact of Debra Freedenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Debra Freedenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Debra Freedenberg more than expected).

Fields of papers citing papers by Debra Freedenberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Debra Freedenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Debra Freedenberg. The network helps show where Debra Freedenberg may publish in the future.

Co-authorship network of co-authors of Debra Freedenberg

This figure shows the co-authorship network connecting the top 25 collaborators of Debra Freedenberg. A scholar is included among the top collaborators of Debra Freedenberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Debra Freedenberg. Debra Freedenberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McGarry, Meghan E., Karen S. Raraigh, Philip M. Farrell, et al.. (2025). Cystic Fibrosis Newborn Screening: A Systematic Review-Driven Consensus Guideline from the United States Cystic Fibrosis Foundation. International Journal of Neonatal Screening. 11(2). 24–24. 3 indexed citations
2.
Lupo, Philip J., Natalie P. Archer, Lisa K. Marengo, et al.. (2024). Newborn screening analytes and structural birth defects among 27,000 newborns. PLoS ONE. 19(7). e0304238–e0304238. 1 indexed citations
3.
McGregor, Tracy L., Susan A. Berry, Katrina M. Dipple, et al.. (2020). Management Principles for Acute Illness in Patients With Medium-Chain Acyl-Coenzyme A Dehydrogenase Deficiency. PEDIATRICS. 147(1). 2 indexed citations
4.
Langlois, Peter H., et al.. (2020). The association between newborn screening analytes as measured on a second screen and childhood autism in a Texas Medicaid population. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 183(6). 331–340. 4 indexed citations
5.
Miller, David T., Debra Freedenberg, Elizabeth K. Schorry, et al.. (2019). Health Supervision for Children With Neurofibromatosis Type 1. PEDIATRICS. 143(5). 117 indexed citations
6.
Canfield, Mark A., et al.. (2019). The association between newborn screening analytes and childhood autism in a Texas Medicaid population, 2010–2012. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 180(5). 291–304. 12 indexed citations
7.
Bonhomme, Natasha, Scott M. Shone, Amy Gaviglio, et al.. (2019). A Newborn Screening Education Best Practices Framework: Development and Adoption. International Journal of Neonatal Screening. 5(2). 22–22. 9 indexed citations
8.
Sontag, Marci K., Rachel Lee, Daniel G. Wright, Debra Freedenberg, & Scott D. Sagel. (2016). Improving the Sensitivity and Positive Predictive Value in a Cystic Fibrosis Newborn Screening Program Using a Repeat Immunoreactive Trypsinogen and Genetic Analysis. The Journal of Pediatrics. 175. 150–158.e1. 32 indexed citations
9.
Moeschler, John B., Michael Shevell, John B. Moeschler, et al.. (2014). Comprehensive Evaluation of the Child With Intellectual Disability or Global Developmental Delays. PEDIATRICS. 134(3). e903–e918. 352 indexed citations
10.
Tinkle, Brad T., Howard M. Saal, Robert A. Saul, et al.. (2013). Health Supervision for Children With Marfan Syndrome. PEDIATRICS. 132(4). e1059–e1072. 34 indexed citations
11.
Summar, Marshall, Stefan Koelker, Debra Freedenberg, et al.. (2013). The incidence of urea cycle disorders. Molecular Genetics and Metabolism. 110(1-2). 179–180. 206 indexed citations
12.
Hashmi, S. Shahrukh, Mark A. Canfield, Lisa K. Marengo, et al.. (2012). The association between neonatal thyroxine and craniosynostosis, Texas, 2004–2007. Birth Defects Research Part A Clinical and Molecular Teratology. 94(12). 1004–1009. 9 indexed citations
13.
Lee, Laura, Mark A. Canfield, S. Shahrukh Hashmi, et al.. (2012). Association between thyroxine levels at birth and choanal atresia or stenosis among infants in Texas, 2004–2007. Birth Defects Research Part A Clinical and Molecular Teratology. 94(11). 951–954. 15 indexed citations
14.
Breman, Amy M., Melissa B. Ramocki, Sung‐Hae Kang, et al.. (2010). MECP2 duplications in six patients with complex sex chromosome rearrangements. European Journal of Human Genetics. 19(4). 409–415. 25 indexed citations
15.
Wat, Margaret, Wojciech Wiszniewski, Trevor Resnick, et al.. (2010). Recurrent microdeletions of 15q25.2 are associated with increased risk of congenital diaphragmatic hernia, cognitive deficits and possibly Diamond–Blackfan anaemia. Journal of Medical Genetics. 47(11). 777–781. 28 indexed citations
16.
Arnold, Georgianne L., Johan Van Hove, Debra Freedenberg, et al.. (2009). A Delphi clinical practice protocol for the management of very long chain acyl-CoA dehydrogenase deficiency. Molecular Genetics and Metabolism. 96(3). 85–90. 112 indexed citations
17.
Freedenberg, Debra, et al.. (2009). Development, testing, and validation of a patient satisfaction questionnaire for use in the clinical genetics setting. American Journal of Medical Genetics Part C Seminars in Medical Genetics. 151C(3). 191–199. 28 indexed citations
18.
Oglesbee, Devin, et al.. (2006). Normal Muscle Respiratory Chain Enzymes Can Complicate Mitochondrial Disease Diagnosis. Pediatric Neurology. 35(4). 289–292. 16 indexed citations
19.
Gloyn, Anna L., Frank Reimann, Christophe A. Girard, et al.. (2005). Relapsing diabetes can result from moderately activating mutations in KCNJ11. Human Molecular Genetics. 14(7). 925–934. 133 indexed citations
20.
Freedenberg, Debra, Louise W. Gane, Carolyn Sue Richards, et al.. (1999). Fragile X syndrome and an isodicentric X chromosome in a woman with multiple anomalies, developmental delay, and normal pubertal development. American Journal of Medical Genetics. 85(3). 197–201. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Asuri N. Prasad Breakdown of academic impact, for papers by Jesús Manuel Eirís Puñal Breakdown of academic impact, for papers by Mitsugu Uematsu Breakdown of academic impact, for papers by Ana Chiesa Breakdown of academic impact, for papers by Harry J. Hirsch Breakdown of academic impact, for papers by Huriya Beyan Breakdown of academic impact, for papers by Warren D. Grover Breakdown of academic impact, for papers by Anna Bergqvist Breakdown of academic impact, for papers by Patrick Rump Breakdown of academic impact, for papers by Federica Zibordi
Rankless by CCL
2026